Skip to content
Lower risk Drug recall · FDA · Published April 12, 2022

American Health Packaging Recalls Cyanocobalamin Injection Due to Subpotent Drug

American Health Packaging recalls 25 vials of Cyanocobalamin Injection (1000 mcg/mL) due to subpotent drug levels. This affects prescription-only medical use. Contact for details.

🇺🇸 FDA recall #D-0790-2022DrugAmerican Health Packaging ›
Take action

Contact the company

Recalling firmAmerican Health Packaging2550 John Glenn Ave Ste A · Columbus, OH 43217-1188
✎ GovInfoNow plain-language explainer

American Health Packaging is recalling 25 vials of Cyanocobalamin Injection (1000 mcg/mL) because the drug concentration is too low. This could lead to ineffective treatment if used as prescribed. Read more at govinfonow.com/recall/34967-american-health-packaging-recalls-cyanocobalamin-injection-due-to-subpotent-drug.

Source Summary by GovInfoNow · govinfonow.com/recall/34967-american-health-packaging-recalls-cyanocobalamin-injection-due-to-subpotent-drug · Updated August 18, 2026 · FDA enforcement record: FDA #D-0790-2022

Cite this page

“American Health Packaging Recalls Cyanocobalamin Injection Due to Subpotent Drug.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34967-american-health-packaging-recalls-cyanocobalamin-injection-due-to-subpotent-drug. Based on FDA recall #D-0790-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0790-2022%22&limit=1).

The FDA announced on April 12, 2022, that American Health Packaging is recalling Cyanocobalamin Injection, USP, due to subpotent drug risks. The recall affects 97,975 vials distributed in Alabama.

How to tell if you have it

  • Brand: American Health Packaging
  • Product: Cyanocobalamin Injection, USP, 1000 mcg per mL, For Intramuscular or Subcutaneous Use Only, 25 x 1 mL Vials, Rx only
  • NDC for Carton: 68001-509-60
  • NDC for vial: 68001-509-59
  • Lots: CCC210008, CCC210009
  • Expiration Date: 01/23

The hazard

The product is subpotent because it is out of specification for assay. The recall classification is Class III.

Context

GovInfoNow's records show American Health Packaging has 41 other recalls on record since July 23, 2012. Other recent recalls include the August 19, 2026 Buprenorphine Tablets recall for label mix-up hazards and the May 3, 2022 Nitrofurantoin Capsules recall for dissolution failure risks. Similar recent recalls of other products include the July 24, 2026 American Regent Cyanocobalamin Injection recall for particulate matter hazards and the November 26, 2025 Somerset Therapeutics Cisatracurium Besylate Injection recall for subpotent product risks.

How to tell if you have this one

Check for vials labeled 'Cyanocobalamin Injection, USP, 1000 mcg per mL, 25 x 1 mL Vials, Rx only'. The NDC for vial is 68001-509-59 and lots CCC210008 or CCC210009.

  • Brand
    American Health Packaging
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the NDC code 68001-509-59 and lot numbers CCC210008 or CCC210009 on the vial.

Where it went and when

Where it was distributed

Distributed in Alabama.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: yesALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “Alabama” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Alabama.

Recall timeline

FDA terminated this recall 9 months after the firm started it.

1. Firm started the recall: Apr 12, 202212. FDA classified it Class III: Apr 26, 202223. Published in FDA’s Enforcement Report: May 4, 202234. FDA terminated the recall: Dec 28, 202242022
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other American Health Packaging recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0790-2022 (April 12, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0790-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA